Enzymatica AB (publ)
ENZY
Rank in Stocks
#21938
Enzymatica AB, a life science company headquartered in Lund, Sweden, focuses on... Enzymatica AB, a life science company headquartered in Lund, Sweden, focuses on the development and sale of medical devices for infection-related illnesses. Founded in 2007, its primary offering is the ColdZyme mouth spray, designed to help prevent and reduce the duration of the common cold. The company also produces various enzyme formulations. This mouth spray is distributed across several European markets under different brand names: ViruProtect in Denmark, STADAProtect in Germany, Psysiomer Stop Virus in France, and Zerinol Virus Defense in Italy.
Share Price
$0.24674616
Last synced: 2026-11-12
Market Cap
$59.89M
Change (1 day)
-2.20%
Change (1 year)
22.71%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Enzymatica AB (publ) (ENZY)
Category
Healthcare
Operating Margin for Enzymatica AB (publ) (ENZY)
Operating Margin as of November 2026 TTM: -79.41%
According to Enzymatica AB (publ)'s latest financial reports, its current operating margin (TTM) is -79.41%. At the end of 2025 the company had an operating margin of -96.86%.
Operating Margin history for Enzymatica AB (publ) from 2010 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -79.41% | -18.02% |
| 2025 | -96.86% | -15.20% |
| 2024 | -114.22% | 20.97% |
| 2023 | -94.42% | -32.25% |
| 2022 | -139.37% | 76.33% |
| 2021 | -79.04% | 629.15% |
| 2020 | -10.84% | -84.05% |
| 2019 | -67.95% | -11.99% |
| 2018 | -77.21% | 51.93% |
| 2017 | -50.82% | -59.85% |
| 2016 | -126.57% | -12.81% |
| 2015 | -145.16% | -15.29% |
| 2014 | -171.36% | 10.89% |
| 2013 | -154.53% | -81.97% |
| 2012 | -857.09% | 1.41% |
| 2011 | -845.19% | 0.00% |
| 2010 | 0.00% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -100.24% |
DE
|
|
| 19.68% | -100.25% |
DE
|
|
| 13.26% | -100.17% |
JP
|
|
| 17.08% | -100.22% |
CH
|
|
| 14.92% | -100.19% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Enzymatica AB (publ)'s operating margin
What is Enzymatica AB (publ)'s operating margin?
Enzymatica AB (publ)'s operating margin is -79.41%, as of Nov 2026.
What was Enzymatica AB (publ)'s operating margin in 2025?
In 2025, Enzymatica AB (publ)'s operating margin was -96.86%, compared with -114.22% in 2024.
How has Enzymatica AB (publ)'s operating margin changed since 2020?
From 2020 to 2025, Enzymatica AB (publ)'s operating margin was highest in 2020 (-10.84%) and lowest in 2022 (-139.37%).
How does Enzymatica AB (publ)'s operating margin compare with similar companies?
Enzymatica AB (publ)'s operating margin (-79.41%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.